Lake Street Sticks to Their Buy Rating for Oncolytics Biotech (ONCY)
at www.tipranks.com (Wed, 25-Feb 11:05 AM)
Oncolytics Biotech gains as enrollments for GIT cancer trial conclude
at seekingalpha.com (Tue, 24-Feb 2:45 PM)
Oncolytics Refocuses Pipeline on Key GI Cancer Programs
at www.tipranks.com (Tue, 24-Feb 9:49 AM)
FDA Fast Track Designation for Pelareorep Signals Major Leap in Colorectal Cancer Therapy
Market Chameleon (Wed, 4-Feb 10:36 AM)
